Type I Interferon Blockade with Anifrolumab in Patients with Systemic Lupus Erythematosus Modulates Key Immunopathological Pathways in a Gene Expression and Proteomic Analysis of Two Phase 3 Trials
Annals of the Rheumatic Diseases(2024)
Key words
Biological Therapy,Lupus Erythematosus, Systemic,Autoimmune Diseases
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined